Effect of Introducing Digital Multimedia Nursing on Improving With COPD (COPD)

February 12, 2026 updated by: CHANG CHIA JUNG, Fu Jen Catholic University Hospital

Effect of Introducing Transtheory-based Digital Multimedia Nursing and Health Education Model on Improving the Self-Care of Older Adult Patients With Chronic Obstructive Pulmonary Disease

COPD is a progressive and irreversible lung disease characterized by persistent airflow limitation, dyspnea, chronic cough, and impaired daily functioning, often accompanied by comorbidities that reduce quality of life. Despite its high prevalence in Taiwan, COPD remains underdiagnosed and undertreated. This study aims to evaluate a transtheoretical model-based digital multimedia nursing education intervention for elderly patients with COPD. The intervention is designed to enhance disease knowledge, promote self-care behaviors, and improve self-management abilities, ultimately supporting better quality of life and daily functioning in this population.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Completed

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Detailed Description

COPD is a chronic and progressive respiratory disease characterized by persistent airflow limitation and symptoms such as dyspnea, chronic cough, and sputum production. The disease significantly impairs daily functioning and quality of life, particularly among older adults. Despite its high prevalence, COPD remains underdiagnosed and inadequately managed in Taiwan.

To improve disease management, digital health education strategies may enhance patients' knowledge and self-care abilities. This study aims to evaluate the effectiveness of a transtheoretical model-based digital multimedia nursing education intervention in improving disease knowledge, self-management behaviors, and quality of life among elderly patients with COPD.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Interventional

Enrollment (Actual)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
51

Phase

Phase

The stage of a clinical trial studying a drug or biological product, based on definitions developed by the U.S. Food and Drug Administration (FDA). The phase is based on the study's objective, the number of participants, and other characteristics. There are five phases: Early Phase 1 (formerly listed as Phase 0), Phase 1, Phase 2, Phase 3, and Phase 4. Not Applicable is used to describe trials without FDA-defined phases, including trials of devices or behavioral interventions.
  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Taiwan
    • Taiwan
      • New Taipei City, Taiwan, Taiwan, 243
        • Taiwan

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  1. Patients diagnosed with pulmonary obstruction after evaluation by a physician.
  2. Elderly people aged 60 years or above.
  3. Those who are literate, have clear consciousness and can communicate in Chinese and Taiwanese.
  4. Those who agree to participate in this research and sign the consent form.

Exclusion Criteria:

  1. Patients with respiratory distress syndrome.
  2. Those who use respirators.
  3. Those who are unable to communicate due to cognitive impairment due to major mental illness or dementia.
  4. Color blindness and visual impairment.
  5. Those who do not have mobile phones or tablet computers at home and cannot obtain electronic equipment.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm

Participant Group / Arm

A group or subgroup of participants in a clinical trial that receives a specific intervention/treatment, or no intervention, according to the trial's protocol.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
Experimental: E-book on Pulmonary Obstruction
A experimental design was adopted. Simple random sampling was performed to divide the subjects into the traditional teaching material-based intervention group and digital teaching material-based intervention group. A total of 51 patients with COPD and aged ≥60 years were recruited from the outpatient department of a hospital in northern Taiwan. The two groups respectively received health education through traditional paper teaching materials and digital multimedia teaching materials; 50-minute interventions were conducted once per week for 8 weeks, and measurements were taken before the interventio, 8 and 12 weeks after the intervention. Regarding the performance indicators, a paired t test and generalized estimating equation (GEE) were used to analyse differences in the COPD Assessment Test (CAT)、self-care efficiency scale for COPD and COPD knowledge scale.
Behavioral: E-book on Pulmonary Obstruction
The digital teaching intervention group used a computer-downloaded "E-book on Pulmonary Obstruction" for one-on-one teaching. The subjects were also taught how to use their mobile phones to download the "E-book on Pulmonary Obstruction" and how to read it, so that they could use it on their own after returning home. The intervention time for both groups was once a week for 50 minutes each time for a total of 8 weeks. The teaching content is divided into eight themes: (1) How much do you know about pulmonary obstruction? (2) Inhalation treatment for pulmonary obstruction - Introduction to inhalers? (3) Care for pulmonary obstruction - Breathing exercise techniques? (4) Activities and exercise training? (5) Self-management methods for acute pulmonary obstruction? (6) Lung rehabilitation for pulmonary obstruction? (7) Nutritional care for pulmonary obstruction? (8) Care for pulmonary obstruction - Smoking cessation?
No Intervention: The traditional teaching material-based group
The traditional teaching intervention group used the same health education content of the "E-book on Pulmonary Obstruction" printed into a paper manual for one-on-one teaching, and the same instructor provided health education guidance.

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
COPD assessment test; CAT
Time Frame: Baseline (Week 1), Week 8, and Week 12
The CAT is an 8-item questionnaire assessing the impact of COPD on health status and daily functioning. Higher scores indicate greater disease burden. This study evaluates the effectiveness of a digital multimedia nursing education intervention in improving disease knowledge, self-care, and self-management.
Baseline (Week 1), Week 8, and Week 12

Secondary Outcome Measures

Secondary Outcome Measures

In a clinical study's protocol, a planned outcome measure that is not as important as the primary outcome measure for evaluating the effect of an intervention but is still of interest. Most clinical studies have more than one secondary outcome measure.
Outcome Measure
Measure Description
Time Frame
Knowledge of COPD Score
Time Frame: Baseline (Week 1), Week 8, and Week 12
Assessed using a validated COPD knowledge questionnaire to evaluate participants' understanding of disease management and self-care principles.
Baseline (Week 1), Week 8, and Week 12
Self-Care Behavior Score
Time Frame: Baseline (Week 1), Week 8, and Week 12
Measured using a self-care behavior scale adapted for COPD, evaluating adherence to recommended lifestyle and symptom management strategies.
Baseline (Week 1), Week 8, and Week 12

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Fu Jen Catholic University Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
May 11, 2020

Primary Completion (Actual)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
August 11, 2021

Study Completion (Actual)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
December 23, 2023

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
August 4, 2025

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
February 12, 2026

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
February 19, 2026

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
February 19, 2026

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
February 12, 2026

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
August 1, 2025

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • FuJenCUH

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on COPD,Pulmonary Disease, Chronic Obstructive ,Pulmonary Disease, Chronic Obstructive

Clinical Trials on E-book on Pulmonary Obstruction

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings